BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37925048)

  • 1. miR-29c-3p acts as a tumor promoter by regulating β-catenin signaling through suppressing DNMT3A, TET1 and HBP1 in ovarian carcinoma.
    Zhao H; Feng L; Cheng R; Wu M; Bai X; Fan L; Liu Y
    Cell Signal; 2024 Jan; 113():110936. PubMed ID: 37925048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.
    Fan L; Lei H; Zhang S; Peng Y; Fu C; Shu G; Yin G
    Theranostics; 2020; 10(13):5895-5913. PubMed ID: 32483426
    [No Abstract]   [Full Text] [Related]  

  • 3. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2.
    Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J
    Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
    Xu H; Mao HL; Zhao XR; Li Y; Liu PS
    J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.
    Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D
    Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
    Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
    Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-365a-3p suppresses proliferation and invasion of Hep-2 cells through targeting ten-eleven translocation 1 (TET1).
    Li J; Shen N; Bai GP; Huang XS
    Neoplasma; 2018 Sep; 65(5):730-735. PubMed ID: 30249104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29c-3p regulates proliferation and migration in ovarian cancer by targeting KIF4A.
    Feng S; Luo S; Ji C; Shi J
    World J Surg Oncol; 2020 Dec; 18(1):315. PubMed ID: 33261630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-301b-3p accelerates migration and invasion of high-grade ovarian serous tumor via targeting CPEB3/EGFR axis.
    Liu F; Zhang G; Lv S; Wen X; Liu P
    J Cell Biochem; 2019 Aug; 120(8):12618-12627. PubMed ID: 30834603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma.
    He S; Yang S; Niu M; Zhong Y; Dan Gao ; Zhang Y; Ma H; Xiong W; Zhou M; Zhou Y; Xiang B; Li G; Shuai C; Peng S
    Cell Death Dis; 2018 Jan; 9(2):100. PubMed ID: 29367693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-29c-3p represses the angiogenesis of esophageal squamous cell carcinoma by targeting SERPINH1 to regulate the Wnt signaling pathway.
    Wei D; Ma Z; Zhu T; Wang H; Wang B; Fu L; Yu G
    Acta Cir Bras; 2023; 38():e385223. PubMed ID: 38055382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-29c Suppresses the Malignant Phenotype of Hepatocellular Carcinoma Cells In Vitro by Mediating TPX2 Associated with Immune Infiltration.
    Wang H; Chen W; Qi Y; Liu D; Liu Z; Zhang Q; Yi Y; Wang J; Wu W
    Dig Dis Sci; 2023 May; 68(5):1923-1935. PubMed ID: 36583803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
    Zhou Y; Zheng X; Lu J; Chen W; Li X; Zhao L
    Cell Physiol Biochem; 2018; 45(6):2548-2559. PubMed ID: 29558748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-suppressor p53 specifically binds to miR-29c-3p and reduces ADAM12 expression in hepatocellular carcinoma.
    Che J; Su Z; Yang W; Xu L; Li Y; Wang H; Zhou W
    Dig Liver Dis; 2023 Mar; 55(3):412-421. PubMed ID: 35853821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway.
    Hu Z; Cai M; Zhang Y; Tao L; Guo R
    Cell Cycle; 2020 Jan; 19(2):193-206. PubMed ID: 31885310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
    Tung CH; Kuo LW; Huang MF; Wu YY; Tsai YT; Wu JE; Hsu KF; Chen YL; Hong TM
    Oncogene; 2020 Jan; 39(4):862-876. PubMed ID: 31570789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-5590-3p inhibits the proliferation and invasion of ovarian cancer cells through mediating the Wnt/β-catenin signaling pathway by targeting TNIK.
    Wu X; Zhong Y; Zhang H; Li M
    Histol Histopathol; 2024 Mar; 39(3):345-355. PubMed ID: 37318197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
    Qiao B; He BX; Cai JH; Tao Q; King-Yin Lam A
    Sci Rep; 2017 Apr; 7():44688. PubMed ID: 28425477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.